| How many human proteoforms are there? R Aebersold, JN Agar, IJ Amster, MS Baker, CR Bertozzi, ES Boja, ... Nature chemical biology 14 (3), 206-214, 2018 | 768 | 2018 |
| Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. SJ McKenzie, MS Baker, GD Buffinton, WF Doe The Journal of clinical investigation 98 (1), 136-141, 1996 | 443 | 1996 |
| Biological and clinical aspects of plasminogen activator inhibitor type 2 EKO Kruithof, MS Baker, CL Bunn Blood 86 (11), 4007-4024, 1995 | 430 | 1995 |
| Open source drug discovery with the malaria box compound collection for neglected diseases and beyond WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ... PLoS pathogens 12 (7), e1005763, 2016 | 294 | 2016 |
| Mechanical stretch: physiological and pathological implications for human vascular endothelial cells NF Jufri, A Mohamedali, A Avolio, MS Baker Vascular cell 7, 1-12, 2015 | 255 | 2015 |
| The human plasma proteome draft of 2017: building on the human plasma PeptideAtlas from mass spectrometry and complementary assays JM Schwenk, GS Omenn, Z Sun, DS Campbell, MS Baker, CM Overall, ... Journal of proteome research 16 (12), 4299-4310, 2017 | 223 | 2017 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 215 | 2022 |
| High‐abundance protein depletion: comparison of methods for human plasma biomarker discovery V Polaskova, A Kapur, A Khan, MP Molloy, MS Baker Electrophoresis 31 (3), 471-482, 2010 | 207 | 2010 |
| Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade N Ahmed, F Pansino, R Clyde, P Murthi, MA Quinn, GE Rice, MV Agrez, ... Carcinogenesis 23 (2), 237-244, 2002 | 181 | 2002 |
| A high-stringency blueprint of the human proteome S Adhikari, EC Nice, EW Deutsch, L Lane, GS Omenn, SR Pennington, ... Nature communications 11 (1), 5301, 2020 | 180 | 2020 |
| Effects of an intensive 12-wk training program by elite swimmers on neutrophil oxidative activity. DB Pyne, MS Baker, PA Fricker, WA McDONALD, RD Telford, ... Medicine and science in sports and exercise 27 (4), 536-542, 1995 | 178 | 1995 |
| Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins HM Georgiou, GE Rice, MS Baker PROTEOMICS: International Edition 1 (12), 1503-1506, 2001 | 163 | 2001 |
| Human proteome project mass spectrometry data interpretation guidelines 2.1 EW Deutsch, CM Overall, JE Van Eyk, MS Baker, YK Paik, ST Weintraub, ... Journal of proteome research 15 (11), 3961-3970, 2016 | 162 | 2016 |
| The effect of pH on the conversion of superoxide to hydroxyl free radicals MS Baker, JM Gebicki Archives of biochemistry and biophysics 234 (1), 258-264, 1984 | 156 | 1984 |
| Standard guidelines for the chromosome-centric human proteome project YK Paik, GS Omenn, M Uhlen, S Hanash, G Marko-Varga, R Aebersold, ... Journal of proteome research 11 (4), 2005-2013, 2012 | 154 | 2012 |
| Mass spectrometry-based plasma proteomics: considerations from sample collection to achieving translational data V Ignjatovic, PE Geyer, KK Palaniappan, JE Chaaban, GS Omenn, ... Journal of proteome research 18 (12), 4085-4097, 2019 | 149 | 2019 |
| Direct integrin αvβ6-ERK binding: implications for tumour growth N Ahmed, J Niu, DJ Dorahy, X Gu, S Andrews, CJ Meldrum, RJ Scott, ... Oncogene 21 (9), 1370-1380, 2002 | 143 | 2002 |
| αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer N Ahmed, C Riley, GE Rice, MA Quinn, MS Baker Journal of Histochemistry & Cytochemistry 50 (10), 1371-1379, 2002 | 139 | 2002 |
| The plasminogen activator inhibitor-2 gene is not required for normal murine development or survival KM Dougherty, JM Pearson, AY Yang, RJ Westrick, MS Baker, D Ginsburg Proceedings of the National Academy of Sciences 96 (2), 686-691, 1999 | 138 | 1999 |
| Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation MS Baker, P Bleakley, GC Woodrow, WF Doe Cancer research 50 (15), 4676-4684, 1990 | 133 | 1990 |
